Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
29681-21-8
31290-76-3
53609-62-4
102867-56-1
52788-79-1
77078-22-9
1122-47-0 | 4-Amino-1-methylpyrimidin-2(1h)-one | AA00830R | MFCD00038058
106492-60-8 | Aminooxy-peg4-alcohol | AA0083O0 | MFCD30828691
105628-70-4 | Isoquinoline,1-chloro-5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]- | AA0084CU | MFCD12031553
1072946-22-5 | 6-(4-Methoxybenzylcarbamoyl)pyridine-3-boronic acid | AA0084ZB | MFCD10699628
103426-20-6 | 3-Chloro-5-methylbenzaldehyde | AA0085NL | MFCD11553565
893612-97-0 | 3-Amino-2-(3,5-dimethylphenylamino)benzoic acid | AA0086CJ | MFCD08056209
890098-26-7 | 2-Fluoro-4'-iodobenzophenone | AA0088LE | MFCD02260398
885272-42-4 | 4-Amino-2,3-dihydro-indole-1-carboxylic acid tert-butyl ester | AA0089LY | MFCD08059274
882678-96-8 | 3-Amino-2-methylphenylboronic acid, pinacol ester | AA008AO1 | MFCD11054038
874908-14-2 | 3'-Hydroxy Repaglinide(Mixture of Diastereomers) | AA008C5C | MFCD16878816
